LRG Webcast: Symptom and Side Effect Management (Hebrew Subtitles)
Originally published in June of 2019, GIST Israel provided Hebrew subtitles for this webcast on Symptom & Side Effect Management.
Originally published in June of 2019, GIST Israel provided Hebrew subtitles for this webcast on Symptom & Side Effect Management.
The Life Raft Group held a GIST Day of Learning (GDOL) in Tampa, at Moffitt Cancer Center, on May 16th, 2019. This was the first GDOL presented in Tampa. GDOLs are free, one-day programs [...]
“You're off to Great Places! Today is your day! Your mountain is waiting, So... get on your way!” ― Dr. Seuss, Oh, The Places You'll Go! Dear SDH-deficient GIST [...]
Are you interested in optimizing your treatment? In 'Optimizing GIST Treatment', this world-renown GIST expert from Europe will share his wealth of experience and insight about how he has helped patients live longer, and [...]
Genetic Testing and SDHx Mutations: What do they have to do with PGL/GIST/Pheos? This webcast highlights how SDHx mutations impact risks for paraganglioma, pheochromocytomas, and GIST, why genetic testing is helpful for any diagnosis [...]
GI Stromal Tumors: A PatholoGIST's Point of View Mutational Testing in GIST Mutational Testing in GIST is a vital component for survival, especially as cancer treatment becomes more individualized. In this webcast, Dr. Chris [...]
Monitoreando la salud del hígado con GIST El hígado (liver), ubicado debajo de la caja toráxica derecha, es el órgano interno más grande del cuerpo y actúa como una fábrica que regula la digestión, [...]
GIST Day of Learning The Life Raft Group held a GIST Day of Learning (GDOL) in Los Angeles, California on February 18th, 2019. GDOLs are free, one-day programs that provide both education and support [...]
Wondering what in the world Gastrointestinal Stromal Tumor (GIST) is? Longtime friend of the Life Raft Group and LRG Science Team member, Dr. David Josephy, presented the basics of cell biology in cancer, focusing [...]
Overall survival in GIST patients has improved dramatically over the years. In 2019, the median Overall Survival (OS) is over 12 years when all Life Raft Group registry patients are combined. About 80% of [...]